Skip to main content

Share story

AI

Notion 3.2: Mobile AI, new models, people directory

Notion 3.2: Mobile AI, new models, people directory Image: Primary
Notion released updates that bring its artificial intelligence tools to mobile devices. One tap initiates AI note transcriptions during calls or meetings, even if the user switches applications or locks the screen. Summaries, action items and shareable documents are generated in seconds. The Notion Agent now operates fully on mobile phones. It performs tasks such as building forms, creating databases and searching company information. Users can assign items from their to-do lists to the agent for background processing. New artificial intelligence models became available for selection. Options include GPT-5.2, Claude Opus 4.5 and Gemini 3. An automatic setting chooses the most suitable model while preserving user context across switches. A People Directory feature was added to show all members of a workspace. The directory appears as a pre-built database that administrators can customize or import from human resources systems. It is reachable by searching for the term People or via the Members section in settings.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Notion and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.